South Africa’s pharmaceutical manufacturing ambitions will depend on resolving fundamental challenges around affordability, scale, procurement and regulatory coordination. This was the overarching sentiment expressed during Trade and Industrial Policy Strategies’ (TIPS’s) Development Dialogue discussion titled “The socioeconomic realities of localising pharmaceutical production”, on June 17.